Produkty 5085-72-3

CAS 5085-72-3 występuje w naszej ofercie pod nazwami: Friedelanol, Friedelinol, Friedelanol, 98%. Oferty producentów: Biosynth, MedChemExpress, Chemat. Dostępne opakowania: 25mg, 50mg, Get quote, 100mg, 250mg, 1g.

Friedelanol
Biosynth
  • opakowanie: 25mg, 50mg
  • Warianty: 2
Zobacz produkt
Friedelinol
MedChemExpress
  • opakowanie: Get quote
  • Warianty: 1
Zobacz produkt
Friedelanol, 98%
Chemat
  • opakowanie: 100mg, 250mg, 1g
  • Warianty: 3
od 33304,40
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

4,4a,6a,6b,8a,11,11,14a-octamethyl-1,2,3,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-hexadecahydropicen-3-ol (CAS 5085-72-3) to związek chemiczny o wzorze sumarycznym C30H52O i masie molowej 428.7 g/mol. Nazwa systematyczna IUPAC: 4,4a,6a,6b,8a,11,11,14a-octamethyl-1,2,3,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-hexadecahydropicen-3-ol. InChIKey: XCDQFROEGGNAER-UHFFFAOYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC30H52O
Masa molowa428.7 g/mol
Nazwa IUPAC4,4a,6a,6b,8a,11,11,14a-octamethyl-1,2,3,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-hexadecahydropicen-3-ol
InChIKeyXCDQFROEGGNAER-UHFFFAOYSA-N
SMILESCC1C(CCC2C1(CCC3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C)C)C)C)C)C)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 3beta-Friedelinol, Friedelinol, Friedelanol, D:A-Friedooleanan-3.alpha.-ol, Friedelan-3.alpha.-ol, D:A-Friedooleanan-3-ol, (3.alpha.)-, Friedelan-3a-ol, Epifriedelanol [M+H]+, XCDQFROEGGNAER-UHFFFAOYSA-N, 4,4a,6b,8a,11,11,12b,14a-Octamethyldocosahydro-3-picenol #
Powiązane formy tego związku
(3S,4R,4aS,6aS,6aS,6bR,8aR,12aR,14aS,14bS)-4,4a,6a,6b,8a,11,11,14a-octamethyl-1,2,3,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-hexadecahydropicen-3-ol C30H52O
Izomery (ten sam wzór sumaryczny)
(3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol C30H52O
(3R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bS)-5a,5b,8,8,11a,13b-hexamethyl-3-propan-2-yl-1,2,3,3a,4,5,6,7,7a,9,10,11,11b,12,13,13a-hexadecahydrocyclopenta[a]chrysen-9-ol C30H52O
(1S,2R,5R,7R,8R,10S,11S,14R,15R)-14-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-8-methoxy-2,15-dimethylpentacyclo[8.7.0.02,7.05,7.011,15]heptadecane C30H52O
(3S,4aR,6aR,6aR,6bR,8aS,12aS,14aR,14bR)-4,4,6a,6b,9,9,12a,14b-octamethyl-1,2,3,4a,5,6,6a,7,8,8a,10,11,12,13,14,14a-hexadecahydropicen-3-ol C30H52O
(1S,3R,6S,8R,11S,12S,15R,16R)-7,7,12,16-tetramethyl-15-[(2R)-6-methylheptan-2-yl]pentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-ol C30H52O
(3S,5R,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol C30H52O
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R,5R)-5-propan-2-yloctan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C30H52O
(3R,4S,5S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-4-prop-2-enyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol C30H52O
(3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6,7,7,7-tetradeuterio-6-(trideuteriomethyl)heptan-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol C30H52O